193 related articles for article (PubMed ID: 11870917)
1. Functional characterization of an anti-estradiol antibody by site-directed mutagenesis and molecular modelling: modulation of binding properties and prominent role of the V(L) domain in estradiol recognition.
Coulon S; Pellequer JL; Blachère T; Chartier M; Mappus E; Chen Sw SW; Cuilleron CY; Baty D
J Mol Recognit; 2002; 15(1):6-18. PubMed ID: 11870917
[TBL] [Abstract][Full Text] [Related]
2. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
[TBL] [Abstract][Full Text] [Related]
3. Two-step in vitro antibody affinity maturation enables estradiol-17beta assays with more than 10-fold higher sensitivity.
Kobayashi N; Oyama H; Kato Y; Goto J; Söderlind E; Borrebaeck CA
Anal Chem; 2010 Feb; 82(3):1027-38. PubMed ID: 20047279
[TBL] [Abstract][Full Text] [Related]
4. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
5. Free energy simulations and MM-PBSA analyses on the affinity and specificity of steroid binding to antiestradiol antibody.
Laitinen T; Kankare JA; Peräkylä M
Proteins; 2004 Apr; 55(1):34-43. PubMed ID: 14997538
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of two anti-estradiol antibodies as deduced from modelling and site-directed mutagenesis experiments.
Bettsworth F; Monnet C; Watelet B; Battail-Poirot N; Gilquin B; Jolivet M; Menez A; Arnaud M; Ducancel F
J Mol Recognit; 2001; 14(2):99-109. PubMed ID: 11301480
[TBL] [Abstract][Full Text] [Related]
7. Highly specific anti-estradiol antibodies: structural characterisation and binding diversity.
Monnet C; Bettsworth F; Stura EA; Le Du MH; Ménez R; Derrien L; Zinn-Justin S; Gilquin B; Sibaï G; Battail-Poirot N; Jolivet M; Ménez A; Arnaud M; Ducancel F; Charbonnier JB
J Mol Biol; 2002 Jan; 315(4):699-712. PubMed ID: 11812141
[TBL] [Abstract][Full Text] [Related]
8. Specific photoaffinity-labeling of Tyr-50 on the heavy chain and of Tyr-32 on the light chain in the steroid combining site of a mouse monoclonal anti-estradiol antibody using C3-, C6-, and C7-linked 5-azido-2-nitrobenzoylamidoestradiol photoreagents.
Rolland de Ravel M; Blachère T; Delolme F; Dessalces G; Coulon S; Baty D; Grenot C; Mappus E; Cuilleron CY
Biochemistry; 2001 Dec; 40(49):14907-20. PubMed ID: 11732911
[TBL] [Abstract][Full Text] [Related]
9. Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.
Burmester J; Spinelli S; Pugliese L; Krebber A; Honegger A; Jung S; Schimmele B; Cambillau C; Plückthun A
J Mol Biol; 2001 Jun; 309(3):671-85. PubMed ID: 11397088
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts.
Boehm MK; Corper AL; Wan T; Sohi MK; Sutton BJ; Thornton JD; Keep PA; Chester KA; Begent RH; Perkins SJ
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):519-28. PubMed ID: 10677374
[TBL] [Abstract][Full Text] [Related]
11. Expanding the conformational diversity by random insertions to CDRH2 results in improved anti-estradiol antibodies.
Lamminmäki U; Paupério S; Westerlund-Karlsson A; Karvinen J; Virtanen PL; Lövgren T; Saviranta P
J Mol Biol; 1999 Aug; 291(3):589-602. PubMed ID: 10448039
[TBL] [Abstract][Full Text] [Related]
12. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
[TBL] [Abstract][Full Text] [Related]
13. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
Solem ST; Brandsdal BO; Smalås A; Jørgensen TØ
Mol Immunol; 2004 Apr; 40(18):1347-60. PubMed ID: 15072853
[TBL] [Abstract][Full Text] [Related]
14. A general method for greatly improving the affinity of antibodies by using combinatorial libraries.
Rajpal A; Beyaz N; Haber L; Cappuccilli G; Yee H; Bhatt RR; Takeuchi T; Lerner RA; Crea R
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8466-71. PubMed ID: 15939870
[TBL] [Abstract][Full Text] [Related]
15. Modulating the binding properties of an anti-17beta-estradiol antibody by systematic mutation combinations.
Lamminmäki U; Westerlund-Karlsson A; Toivola M; Saviranta P
Protein Sci; 2003 Nov; 12(11):2549-58. PubMed ID: 14573866
[TBL] [Abstract][Full Text] [Related]
16. Structure and dynamics of the anti-AMCV scFv(F8): effects of selected mutations on the antigen combining site.
Arcangeli C; Cantale C; Galeffi P; Rosato V
J Struct Biol; 2008 Oct; 164(1):119-33. PubMed ID: 18662789
[TBL] [Abstract][Full Text] [Related]
17. Dissection of the IgNAR V domain: molecular scanning and orthologue database mining define novel IgNAR hallmarks and affinity maturation mechanisms.
Fennell BJ; Darmanin-Sheehan A; Hufton SE; Calabro V; Wu L; Müller MR; Cao W; Gill D; Cunningham O; Finlay WJ
J Mol Biol; 2010 Jul; 400(2):155-70. PubMed ID: 20450918
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code.
Fellouse FA; Barthelemy PA; Kelley RF; Sidhu SS
J Mol Biol; 2006 Mar; 357(1):100-14. PubMed ID: 16413576
[TBL] [Abstract][Full Text] [Related]
19. N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties.
Saviranta PJauria P; Lamminmäki U; Hellman J; Eriksson S; Lövgren T
Protein Sci; 2000 Dec; 9(12):2547-56. PubMed ID: 11206076
[TBL] [Abstract][Full Text] [Related]
20. The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
Masuda K; Sakamoto K; Kojima M; Aburatani T; Ueda T; Ueda H
FEBS J; 2006 May; 273(10):2184-94. PubMed ID: 16649995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
